Assistant Professor, Faculty of Medicine, McGill University.
Director of the Interdisciplinary Memory Clinic, CHU of Quebec-Laval Univeristy, l’Enfant-Jésus Hospital.
In the early 70s, Dr. Bouchard founded the Quebec Interdisciplinary Memory Clinic (CIME), the oldest memory clinic in Canada. Over the years, he has assembled a team of nine specialist physicians, representing cognitive neurology, geriatrics, neuropsychiatry and geriatric psychiatry. After studying medicine and obtaining a master’s degree in neurobiology from Laval University, Dr. Bouchard completed a training in Cognitive and Behavioral Neurology at Boston City Hospital at Harvard University under the supervision of Prof. Norman Geschwind, followed by a fellowship at the hospital of La Salpêtrière de Paris under the supervision of Professor François Lhermitte. Dr. Bouchard is recognized by his peers as a pioneer in the field of cognitive neurology. The Quebec network of memory clinics and the organizing committee of the first Quebec congress on Alzheimer’s disease created in 2012 the “Rémi W Bouchard” award, presented at each conference for the next generation of scientists. He is also recognized nationally for his outstanding contribution to the understanding and treatment of patients with cognitive impairment, by receiving the “Irma M. Parhad Award” in 2014. At the request of the international journal Lancet Neurology, which publishes career profiles, colleagues at the Memory Clinic summarized his career profile, which was published in May 2017. He was recently honored by the Canadian Medical Association in Montreal. He co-founded the Alzheimer Society of Quebec 32 years ago, and is currently a member of its board of executives. He is also a member of the C5R, the Canadian Society of Neurology, and of the FRSQ research centre of the CHU of Quebec at l’Enfant-Jésus Hospital. He is a member of the executive of the Quebec congress on Alzheimer’s disease. Being responsible for a large number of conferences to the general public, he has always been very involved at the socio-community and humanitarian levels.
For more than 45 years, Dr. Bouchard has been actively involved in teaching cognitive neurology (over 415 courses or conferences). In research, he has been particularly interested in the clinical profile, early diagnosis, and treatment of neurodegenerative diseases, mainly Alzheimer’s disease. He has participated in numerous therapeutic clinical trials in collaboration with the international scientific community. He is the author or co-author of over 125 scientific or abstract publications, as well as of several book chapters in the cognitive or cerebrovascular field. He works closely with other CIME members on a variety of clinical, epidemiological, therapeutic, genetic and imaging research projects in the field of neurodegenerative diseases.
Canada G1J 1Z4
Data not available
Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study.Journal Article
J Neurol Sci, 240 (1-2), pp. 7-14, 2006, ISSN: 0022-510X.
Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias.Journal Article
Dement Geriatr Cogn Disord, 22 (5-6), pp. 413-20, 2006, ISSN: 1420-8008.
Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease.Journal Article
Brain Res, 1003 (1-2), pp. 26-35, 2004, ISSN: 0006-8993.
A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results.Journal Article
Neuroepidemiology, 22 (5), pp. 265-74, 2003, ISSN: 0251-5350.
Fulminating adult-onset subacute sclerosing panencephalitis in a 49-year-old man.Journal Article
Arch Neurol, 60 (8), pp. 1160-1, 2003, ISSN: 0003-9942.
Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease.Journal Article
Arch Neurol, 59 (6), pp. 955-62, 2002, ISSN: 0003-9942.
Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications.Journal Article
Clin Ther, 22 (12), pp. 1549-61, 2000, ISSN: 0149-2918.
A cluster of Friedreich's ataxia in Rimouski, Quebec.Journal Article
Can J Neurol Sci, 6 (2), pp. 205-8, 1979, ISSN: 0317-1671.
Electroencephalographic findings in Friedreich's ataxia and autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).Journal Article
Can J Neurol Sci, 6 (2), pp. 191-4, 1979, ISSN: 0317-1671.
Electromyography and nerve conduction studies in Friedreich's ataxia and autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).Journal Article
Can J Neurol Sci, 6 (2), pp. 185-9, 1979, ISSN: 0317-1671.